Homepage
Medication Guide
Basic Drug Information and Mechanism of Action
Minoxidil (Loniten) is a potent oral peripheral vasodilator primarily used for the treatment of severe, refractory hypertension.Basic Drug Information and Mechanism of Action1. Drug PropertiesMinoxidi...
507
Friday, February 6th, 2026, 11:47
Common and Serious Adverse Reactions of Minoxidil
Minoxidil (Loniten), a potent antihypertensive medication, exerts robust antihypertensive effects while also posing a risk of a range of potential adverse reactions.Common and Serious Adverse Reaction...
516
Friday, February 6th, 2026, 11:22
Side Effects of Ixazomib (Ninlaro)
Ixazomib (Ninlaro) is an oral proteasome inhibitor, which is usually administered in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have receiv...
504
Thursday, February 5th, 2026, 11:42
Precautions for Taking Ixazomib (Ninlaro)
Ixazomib (Ninlaro) is an oral proteasome inhibitor used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy.P...
515
Thursday, February 5th, 2026, 11:33
Common and Serious Adverse Reactions of Teplizumab​
Teplizumab, as an innovative immunomodulator, can delay the onset of type 1 diabetes while potentially causing a range of manageable adverse effects.Common and Serious Adverse Reactions of Tepliz...
518
Wednesday, February 4th, 2026, 09:48
Administration and Dosage of Teplizumab
Teplizumab, the first immunomodulator to delay the onset of type 1 diabetes, requires standardized use and comprehensive management to ensure its efficacy.Administration and Dosage of Teplizumab1...
510
Wednesday, February 4th, 2026, 09:20
Indications of Entrectinib (Rozlytrek)
Entrectinib (Rozlytrek) is a targeted anticancer agent indicated for patients with tumors harboring specific gene mutations. IndicationsEntrectinib is primarily indicated for the treatment of the...
512
Tuesday, February 3rd, 2026, 10:13
Common Adverse Reactions and Clinical Manifestations
Entrectinib (Rozlytrek) is a targeted drug indicated for the treatment of tumors with specific gene mutations.Common Adverse Reactions and Clinical Manifestations1. Systemic Reactions(1) Fatigue is on...
508
Tuesday, February 3rd, 2026, 09:19
What are the Precautions for Mavacamten (Camzyos) Administration?
Mavacamten (Camzyos) is a novel cardiac myosin inhibitor indicated for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) of New York Heart Association (NYH...
510
Monday, February 2nd, 2026, 10:32
Adverse Effects of Mavacamten (Camzyos)
Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of adult patients with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy...
522
Monday, February 2nd, 2026, 10:26
17 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved